Clinically proven BB-12® probiotic drops for gut & immunity
BioDrop™ is a liquid probiotic drop formulated with Bifidobacterium animalis subsp. lactis BB-12® (BB-12®), a patented and clinically proven probiotic strain. BB-12® is the world’s most documented Bifidobacterium, with over 200 human clinical studies that support its wide range of health benefits on gastrointestinal and immune functions. BioDrop™ helps to promote a balanced microflora in our gut and support healthy digestive and immune systems of all ages.
Contains BB-12®, the world's most documented Bifidobacterium
Clinically proven to support healthy gut & immune system
Safe, effective & suitable for all ages including preterm infants
No refrigeration required for ease of storage
What is BioDrop™?
BioDrop™ is a probiotic drop formulated with the patented and clinically proven Bifidobacterium animalis subsp. lactis BB-12® (BB-12®), and contains the scientifically recommended dose of minimum 1 billion CFU per dose.
BB-12® is the world’s most documented probiotic strain with benefits established since 1983. Recorded in over 400 scientific publications, including more than 200 human clinical studies, BB-12® has been clinically shown to support and maintain gut as well as immune health for people of all ages. Therefore, BioDrop is formulated to promote a balanced microbiota for the development of healthy, active digestive and immune systems.
BioDrop™ is specially formulated for a wide range of people including preterm infants, children, adults and elderly as well as those who have difficulty swallowing tablets or capsules. It comes in a user-friendly liquid drop form with an integrated dropper system for convenience. This allows for a precise amount to be easily administered each time with minimal risk of contamination.
How does BioDrop™ help?
Maintains healthy balance of digestive flora
Improves immune functions
Lowers risk of infant diarrhoea
Reduces infant colic
Why choose BioDrop™?
BioDrop™ is specially formulated with BB-12®, a strain-specific live probiotic that is extensively studied and widely used due to its well-established health benefits and good safety profile. BioDrop™ is suitable for people of all ages, ranging from pre-term infants to the elderly. Only 6 drops of BioDrop are needed to provide the clinically recommended dose of BB-12® to promote an ideal balance of gut microflora for healthy gastrointestinal and stronger immune functions.
Contains BB-12®, extensively studied in >200 human clinical trials 
Free of common allergens
such as gluten, shellfish, fish, eggs, soybeans, milk, nuts
Clinically recommended dose of 1 billion CFU of BB-12®
Suitable for vegetarians & vegans
Safety of BB-12® certified by US FDA (GRAS*) & EFSA (QPS*) [3,4]
Made in GMP* certified facility in Italy ensuring high quality & safety
GRAS: Generally Recognised as Safe is a designation granted by the US Food and Drug Administration (FDA) for the safe use of a chemical or substance evaluated by experts.
QPS: Qualified Presumption of Safety is a status granted by the European Food Safety Authority (EFSA) for the safe and authorised use of microorganisms.
GMP: Good Manufacturing Practices are established regulations for manufacturers to ensure that products are consistently produced and controlled according to high quality standards.
Eskesen D, Jespersen L, et al. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br J Nutr. 2015.
Chr. Hansen. Bifidobacterium, BB-12® The world’s most documented Bifidobacterium. https://www.chr-hansen.com/en/probiotic-supplements-and-infant-formula/our-probiotic-strains/bifidobacterium-animalis-subsp-lactis-bb-12
Food and Drug Administration. GRAS Notice Inventory > Agency Response Letter GRAS Notice No GRN 000049. 2002.
EFSA Panel on Biological Hazards (BIOHAZ). Statement on the update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 3: Suitability of taxonomic units notified to EFSA until September 2015. EFSA Journal. 2015.
Jungersen M, Wind A, et al. The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12®. Microorganisms. 2014.
Chouraqui JP, Van Egroo LD, Fichot MC. Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr. 2004.
Nocerino R, De Filippis F, et al. The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12® in infant colic: A randomised, double blind, placebo-controlled trial. Aliment Pharmacol Ther. 2020.
Taipale T, Pienihäkkinen K, Isolauri E, et al. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br J Nutr. 2011.
Taipale TJ, Pienihäkkinen K, Isolauri E, Jokela JT, Söderling EM. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood. Pediatr Res. 2016.